Mei Zhong Selected Research

Antigens

6/2011	Aberrant cytoplasmic expression of cyclin B1 protein and its correlation with EBV-LMP1, P53 and P16(INK4A) in classical Hodgkin lymphoma in China.
1/2005	[Morphology and immunohistochemical characteristics of hepatic primary and metastatic malignant spindle cell tumors].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mei Zhong Research Topics

Disease

28	Pre-Eclampsia (Preeclampsia) 01/2023 - 01/2012
24	Neoplasms (Cancer) 11/2022 - 01/2002
7	Inflammation (Inflammations) 04/2024 - 09/2015
6	Infections 01/2020 - 12/2006
6	Ovarian Neoplasms (Ovarian Cancer) 07/2019 - 06/2006
5	Lymphatic Metastasis 01/2019 - 10/2002
5	Carcinoma (Carcinomatosis) 11/2012 - 01/2005
4	Alzheimer Disease (Alzheimer's Disease) 03/2024 - 01/2022
4	Autistic Disorder (Autism) 08/2023 - 12/2014
4	Gestational Diabetes (Gestational Diabetes Mellitus) 07/2021 - 06/2011
4	Hodgkin Disease (Hodgkin's Disease) 06/2011 - 05/2006
3	Neuroinflammatory Diseases 03/2024 - 01/2023
3	Fetal Growth Retardation (Intrauterine Growth Retardation) 12/2023 - 12/2004
3	Dysbiosis 12/2023 - 01/2020
3	Hemorrhage 11/2022 - 07/2014
3	Necrosis 01/2022 - 04/2005
3	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 07/2021 - 02/2003
3	Premature Birth (Birth, Premature) 01/2021 - 11/2017
3	Proteinuria 01/2020 - 01/2012
3	Thalassemia 06/2019 - 02/2012
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019 - 12/2006
3	Neoplasm Metastasis (Metastasis) 12/2017 - 03/2008
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2017 - 08/2014
3	Adenocarcinoma 07/2017 - 08/2009
3	Carcinogenesis 02/2015 - 01/2008
2	Placenta Accreta 12/2023 - 03/2017
2	Periodontitis 11/2022 - 01/2020
2	Body Weight (Weight, Body) 11/2022 - 12/2004
2	Hypoxia (Hypoxemia) 01/2022 - 01/2019
2	Aneuploidy (Aneuploid) 01/2022 - 01/2010
2	Rupture 07/2021 - 09/2015
2	Seizures (Absence Seizure) 01/2021 - 01/2020
2	COVID-19 01/2021 - 01/2020
2	Lung Neoplasms (Lung Cancer) 10/2020 - 10/2002
2	Congenital Abnormalities (Deformity) 03/2020 - 09/2017
2	Colorectal Neoplasms (Colorectal Cancer) 11/2019 - 04/2002
2	Preterm Premature Rupture of the Membranes 01/2017 - 09/2015
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 10/2009
2	Pregnancy Complications 10/2014 - 04/2012
2	Breast Neoplasms (Breast Cancer) 08/2014 - 02/2008
2	Endometrial Neoplasms (Endometrial Cancer) 08/2014 - 05/2010

Drug/Important Bio-Agent (IBA)

25	Proteins (Proteins, Gene)FDA Link 04/2024 - 04/2002
7	Long Noncoding RNAIBA 01/2023 - 09/2015
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
6	CytokinesIBA 03/2024 - 04/2005
6	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 12/2006
5	CreatinineIBA 01/2020 - 01/2012
5	fragile histidine triad proteinIBA 01/2008 - 04/2002
5	Histidine (L-Histidine)FDA Link 01/2008 - 04/2002
4	Advanced Oxidation Protein Products (AOPP)IBA 01/2023 - 01/2013
4	Messenger RNA (mRNA)IBA 01/2021 - 04/2009
4	ErbB Receptors (EGF Receptor)IBA 10/2020 - 08/2009
4	MicroRNAs (MicroRNA)IBA 01/2020 - 05/2010
4	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 01/2001
4	ParaffinIBA 12/2006 - 01/2002
3	Eosine Yellowish-(YS) (Eosin)IBA 12/2023 - 01/2005
3	Hematoxylin (Haematoxylon)IBA 12/2023 - 01/2005
3	trimethyloxamine (trimethylamine N-oxide)IBA 12/2023 - 01/2019
3	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2015
3	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2022 - 06/2012
3	CollagenIBA 01/2021 - 09/2015
3	Indicators and Reagents (Reagents)IBA 01/2017 - 01/2012
3	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 05/2015 - 06/2012
3	Uric Acid (Urate)IBA 01/2013 - 03/2012
3	Antithrombin IIIIBA 10/2009 - 01/2003
3	von Willebrand FactorIBA 01/2005 - 01/2003
3	Formaldehyde (Formol)FDA Link 10/2002 - 01/2002
2	Caspase 3 (Caspase-3)IBA 04/2024 - 01/2010
2	Amyloid beta-PeptidesIBA 03/2024 - 01/2023
2	Amyloid (Amyloid Fibrils)IBA 12/2023 - 01/2022
2	Therapeutic UsesIBA 11/2022 - 01/2021
2	arginine methyl esterIBA 01/2022 - 03/2021
2	Cyclophilin AIBA 01/2022 - 11/2020
2	Saline SolutionIBA 03/2021 - 12/2018
2	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 01/2021 - 01/2015
2	Pentylenetetrazole (Metrazol)IBA 01/2021 - 01/2020
2	Tyrosine Kinase InhibitorsIBA 10/2020 - 08/2009
2	Immunoglobulins (Immunoglobulin)IBA 03/2020 - 12/2017
2	NF-kappa B (NF-kB)IBA 01/2020 - 01/2010
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 12/2016
2	Cell-Free Nucleic AcidsIBA 06/2019 - 12/2012
2	ORALIT (ORS)IBA 01/2019 - 08/2016
2	Transcription Factors (Transcription Factor)IBA 12/2017 - 02/2015
2	Green Fluorescent ProteinsIBA 10/2017 - 03/2008
2	UbiquitinIBA 01/2017 - 09/2015
2	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2017 - 09/2015
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2016 - 08/2014
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2015 - 01/2015
2	Tissue Inhibitor of Metalloproteinase-1IBA 10/2014 - 01/2001
2	Cystatin CIBA 01/2013 - 07/2012
2	AlbuminsIBA 03/2012 - 01/2012
2	AntigensIBA 06/2011 - 01/2005

Therapy/Procedure

9	Therapeutics 11/2022 - 09/2006
4	Cesarean Section (Caesarean Section) 07/2021 - 04/2012
3	Transplantation 12/2023 - 03/2008
2	Injections 01/2021 - 06/2012
2	Lasers (Laser) 07/2019 - 04/2019
2	Cochlear Implantation 09/2017 - 12/2016
2	Drug Therapy (Chemotherapy) 01/2017 - 11/2012
2	Neoadjuvant Therapy 01/2017 - 08/2014